Antimitotic Agents: all 5,052 studies that test it

Page 33 of 51. Open to participants first (616), then studies with results posted, then the rest; newest registration first within each.

• BRCA1-associated DNA Repair Dysfunction in Patients With Early Triple Negative Breast Cancer Treated With Neoadjuvant Platinum-based ChemotherapyCompletedNCT01672671Phase 2
• Pharmacogenomic Study of Neoadjuvant Eribulin for HER2 Non-overexpressing Breast CancerCompletedNCT01669252Phase 2
• Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With CabazitaxelCompletedNCT01668459Phase 2/3
• Clinical Study of Albumin-bound Paclitaxel Plus Nedaplatin in Cervical CancerStatus unknownNCT01667211Phase 2
• Pilot Study Investigating the Metabolic Activity and Transcriptional Profiling in Vivo in Tumor Biopsies in Melanoma Patients During Treatment With Pazopanib Alone and in Combination With PaclitaxelCompletedNCT01666418Phase 2
• An Open-label, Multi-center Phase Ⅳ Trial to Evaluate the Efficacy and Safety of Sequential Neoadjuvant Chemotherapy With Docetaxel(Monotaxel®) After Doxorubicin Plus Cyclophosphamide Combination Chemotherapy in Locally Advanced Breast CancerCompletedNCT01660542Phase 4
• ICON8: Weekly Chemotherapy in Ovarian CancerStatus unknownNCT01654146Phase 3
• Study to Evaluate Safety & Tolerability of BMS-906024 in Combination With Chemotherapy & to Define DLTs & MTD of BMS-906024 in Combination With One of the Following Chemotherapy Regimens; Weekly Paclitaxel, 5FU+Irinotecan or Carboplatin+Paclitaxel in Subjects With Advanced / Metastatic Solid TumorsCompletedNCT01653470Phase 1
• Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung CancerCompletedNCT01652820Phase 2
• Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian CancerStatus unknownNCT01650376Phase 1/2
• Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate CancerCompletedNCT01649635Phase 4
• Efficacy and Safety With Albumin-bound Paclitaxel (Abraxane) in the TAC as Neoadjuvant Chemotherapy in Breast CancerStatus unknownNCT01647672Phase 2/3
• Efficacy and Safety Study of ABI-007 Plus Capecitabine as First-line Chemotherapy for Advanced Gastric Cancer PatientsStatus unknownNCT01641783Phase 2
• "Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer"Status unknownNCT01641406Phase 2
• Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the StomachCompletedNCT01640782Phase 3
• Safety and Exploratory Efficacy of Kanglaite Injection in Non Small Cell Lung CancerTerminatedNCT01640730Phase 2
• Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial CancerWithdrawnNCT01639521Phase 2
• Study of Vemurafenib, Carboplatin, and PaclitaxelCompletedNCT01636622Phase 1
• Neoadjuvant Study of Nab-paclitaxel Plus Carboplatin in Breast CancerStatus unknownNCT01625429Phase 2
• BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer PatientsWithdrawnNCT01624493Phase 1/2
• A Phase II, Open-Label, Multicenter Trial of Cabazitaxel in Patients With Recurrent or Metastatic Head and Neck Cancer After Failure Of Cisplatin, Cetuximab and TaxanesCompletedNCT01620242Phase 2
• Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate CancerCompletedNCT01619813Phase 2
• Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer PatientsStatus unknownNCT01618474Phase 2
• A Study of Veliparib in Combination With Carboplatin and Paclitaxel in Japanese Subjects With Solid TumorsCompletedNCT01617928Phase 1
• Docetaxel Lipid Microsphere (DT-LM) for Injection in Chemotherapy PatientsStatus unknownNCT01611961Phase 1
• Tesetaxel Every 3 Weeks vs Weekly vs Capecitabine as 1st-line Therapy for Locally Advanced or Metastatic Breast CancerStatus unknownNCT01609127Phase 2
• [18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian CancerCompletedNCT01608009Phase 1
• A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid MalignanciesSuspendedNCT01604863Phase 1
• A Trial of Cabazitaxel for Advanced Transitional Cell Carcinoma (TCC)CompletedNCT01600339Phase 2
• Local Delivery of Paclitaxel Via the TAPAS Catheter to Prevent Restenosis From Percutaneous Femoropopliteal InterventionStatus unknownNCT01599078Not applicable
• JAVLOR Association Study in CDDP-unfit Patients With Advanced Transitional Cell Carcinoma: Gemcitabine Versus CarboplatinCompletedNCT01599013Phase 2
• GP VS TP in the Treatment of Advanced Nasopharyngeal Carcinoma in Northwest ChinaCompletedNCT01596868Phase 2
• Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate CancerCompletedNCT01594918Phase 1
• Concurrent Chemoradiotherapy With Weekly Cisplatin Versus Concurrent Chemoradiotherapy With Weekly Cisplatin and Paclitaxel in Locally Advanced Carcinoma CervixStatus unknownNCT01593306Phase 3
• A Phase III Study of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal CarcinomaCompletedNCT01591135Phase 3
• Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of Sorafenib and Eribulin in CombinationCompletedNCT01585870Phase 1
• Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto)CompletedNCT01583426Phase 3
• Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung CancerCompletedNCT01577654Phase 2
• Continued Treatment With Docetaxel Versus Switch to Cabazitaxel After Minor Prostate Specific Antigen Response to Docetaxel in Patients With Castration-Resistant Metastatic Prostate CancerCompletedNCT01576029Phase 2
• Capecitabine/Tesetaxel Versus Capecitabine/Placebo as Second-line Therapy for Gastric CancerStatus unknownNCT01573468Phase 2
• Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular DegenerationCompletedNCT01570790Phase 1/2
• A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal CancerStatus unknownNCT01570582Phase 2
• Dose-dense Biweekly Docetaxel Combined With 5-fluorouracil as First-line Treatment in Advanced Gastric CancerCompletedNCT01567618Phase 2
• Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced Cervical CancerActive, not recruitingNCT01566240Phase 3
• Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC)WithdrawnNCT01562301Phase 1
• Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid CancersCompletedNCT01560325Phase 1
• Second-line Chemotherapy in Castration Resistant Prostate CancerCompletedNCT01558219Phase 2
• Using Genetic Polymorphisms to Predict the Efficacy and Toxicity - A Gastric Adenocarcinoma StudyTerminatedNCT01558011Phase 2
• Phase I/II Study of Abraxane in Recurrent and Refractory LymphomaTerminatedNCT01555853Phase 1
• COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 Trial)Status unknownNCT01552187Phase 3
• A Phase II Study of Abraxane Gemcitabine Combination in Patients With Metastatic Breast CancerCompletedNCT01550848Phase 2
• Determination of Dose of Antiangiogenic Multitargeted DOVITINIB (TKI258) Plus Paclitaxel in Patients With Solid TumorsTerminatedNCT01548924Phase 1
• PI3K Inhibitor BKM120 and Docetaxel in Treating Patients With Advanced Solid Tumor That is Locally Advanced, Cannot Be Removed By Surgery, or MetastaticCompletedNCT01540253Phase 1
• Trial of Neoadjuvant EndoTAG-1 in Combination With Paclitaxel in HER2-negative Breast CancerCompletedNCT01537536Phase 2
• Biochemical Recurrence Rate of Radical Prostatectomy Combined With Neoadjuvant and Adjuvant Chemotherapy in High Risk Prostate CancerStatus unknownNCT01530295Not applicable
• Clinical Trial With Vinflunine as Maintenance Therapy in Metastatic Urothelial CancerCompletedNCT01529411Phase 2
• Salvage Chemotherapy of Vinorelbine Plus Oxaliplatin in Metastatic Triple-negative Breast Cancer:a Prospective TrialStatus unknownNCT01528826Phase 2
• Study Comparing Two Treatments in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT01528163Phase 2
• Metformin in Children With Relapsed or Refractory Solid TumorsCompletedNCT01528046Phase 1
• Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal ImpairmentCompletedNCT01527929Phase 1
• Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Rituximab Pateinets With Aggresive NHLCompletedNCT01527422Phase 1/2
• Docetaxel With or Without Metronomic Cyclophosphamide as First Line Chemotherapy in Metastatic Breast CancerStatus unknownNCT01526499Phase 2
• Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic NeoplasmTerminatedNCT01525706Phase 1
• Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological CancersCompletedNCT01523678Phase 2
• Study of Weekly Cabazitaxel for Advanced Prostate CancerCompletedNCT01518283Phase 2
• A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine and Protocolized Surgery in Resectable Gastric CancerCompletedNCT01517009Phase 2
• Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk PatientsCompletedNCT01516580Phase 3
• Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab EvaluationCompletedNCT01516567Phase 2
• Intraperitoneal Therapy For Ovarian Cancer With Carboplatin TrialCompletedNCT01506856Phase 2/3
• Auto Transplant for High Risk or Relapsed Solid or CNS TumorsCompletedNCT01505569Not applicable
• Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric AdenocarcinomasCompletedNCT01504256Phase 2
• Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior ChemotherapyCompletedNCT01497964Phase 1/2
• A Clinical Study in Cancer Patients to Investigate the Potential Impact of Custirsen, on the Blood Levels of the Chemotherapeutic Drug, Paclitaxel, When Given Together as Part of a Treatment RegimenCompletedNCT01497470Phase 1
• A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line TreatmentStatus unknownNCT01497041Phase 2
• A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab (Avastin) Plus Platinum And Paclitaxel or With Pemetrexed Plus Platinum in Patients With Non-Squamous Non-Small Cell Lung CancerCompletedNCT01496742Phase 2
• Phase Ib/II Trial of BEZ235 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast CancerTerminatedNCT01495247Phase 1/2
• A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Participants With Advanced Solid TumorsCompletedNCT01494688Phase 1
• A Study of Oraxol® in Gastric Cancer PatientsStatus unknownNCT01491217Phase 1/2
• Clinical Trial to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of Oral Paclitaxel in Patients With Advanced Solid CancerCompletedNCT01491204Phase 1
• Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic CancerCompletedNCT01488552Phase 1/2
• Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryCompletedNCT01486602Phase 1
• A Phase II Neo-adjuvant Study Assessing TCH (Docetaxel, Carboplatin and Trastuzumab) and TCHL (Docetaxel, Carboplatin, Trastuzumab and Lapatinib) in HER-2 Positive Breast Cancer Patients.CompletedNCT01485926Phase 2
• EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian CancerCompletedNCT01485848Phase 2
• Oral Colchicine in Men With Castrate Resistant Prostate CancerWithdrawnNCT01481233Phase 2
• A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT01479504Phase 3
• Trial of Neoadjuvant Endostar, Docetaxel and Epirubicin for Patients With Breast CancerStatus unknownNCT01479036Phase 3
• A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid TumorsCompletedNCT01478685Phase 1
• OPTIMAL>60 / DR. CHOP, Improvement of Therapy of Elderly Patients with CD20+ DLBCL Using Rituximab Optimized and Liposomal VincristineCompletedNCT01478542Phase 3
• Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or StomachCompletedNCT01472029Phase 2
• Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric CancerCompletedNCT01471470Phase 2
• Sequential HIPEC of Oxaliplatin and Paclitaxel for Gastric Cancer Patients With Peritoneum MetastasisStatus unknownNCT01471132Phase 2
• Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell CancerCompletedNCT01469598Phase 2
• Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With DocetaxelTerminatedNCT01469338Phase 2
• Induction Chemotherapy Followed by Cetuximab and Radiation Therapy for Head and Neck CancerCompletedNCT01467115Phase 2
• International Pleuropulmonary Blastoma (PPB) Treatment and Biology RegistryActive, not recruitingNCT01464606Not applicable
• A Study of the Effect of Vinca Alkaloids on c-Jun N-terminal Kinase (JNK) Phosphorylation in Patients With Chronic Lymphocytic Leukemia (CLL)TerminatedNCT01463852Early Phase 1
• Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial CancerStatus unknownNCT01461746Phase 2
• Sequential Treatment of CD20-positive Posttransplant Lymphoproliferative Disorder (PTLD)TerminatedNCT01458548Phase 2
• A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or CarcinosarcomaStatus unknownNCT01454479Phase 1
• A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and CisplatinStatus unknownNCT01444547Phase 2

← Antimitotic Agents overview